Pharmaceutical

Astellas and PeptiDream enter protein degrader discovery deal

Astellas Pharma has entered a research partnership and licence agreement with PeptiDream for the discovery of new targeted protein degraders.

Jul 25, 2023 - 20:00
Astellas and PeptiDream enter protein degrader discovery deal
Astellas Pharma has entered a research partnership and licence agreement with PeptiDream for the discovery of new targeted protein degraders.
Read the original article

Tags:

Previous Article

Roche snubs SQZ HPV 16 programme, leaving the beleaguered company in the lurch

Next Article

Alvotech and Teva step up biosimilars partnership

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Illumina says it will divest Grail, starting a closing chapter for a disastrous deal

STAT+: Illumina says it will divest Grail, starting a c...

Dec 17, 2023

STAT+: Doudna institute hatches plan to ‘cure hundreds of diseases’ left behind by CRISPR revolution

STAT+: Doudna institute hatches plan to ‘cure hundreds ...

Jan 10, 2024

Listen: Fake medical devices, real cancer drugs, & curious Ozempic effects

Listen: Fake medical devices, real cancer drugs, & curi...

Jun 2, 2023